Advanced Search
Contact | Corporate | Help

A Study of RO5072759 (GA101) in Combination With CHOP Chemotherapy in Patients With Previously Untreated Advanced Diffuse Large B-Cell Lymphoma

Sponsors:
  • Genentech
Phases:
  • Phase II
IndicationsAcronym:
  • Lymphoma, B-Cell
Age Groups:
  • Adult
  • Senior
Gender:
Both
Names:
  • Drug: RO50722759
  • Drug: cyclophosphamide
  • Drug: doxorubicin
  • Drug: vincristine
  • Drug: prednisone
Enrollment:
80

Additional information about NCT01414855.


SourceSolution © 2008-2012